The Development of COVID-19 Vaccines: Safeguards Needed

JAMA. 2020 Aug 4;324(5):439-440. doi: 10.1001/jama.2020.12461.
No abstract available

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Biomedical Research / trends*
  • COVID-19
  • COVID-19 Vaccines
  • Clinical Trials as Topic / standards
  • Coronavirus Infections / prevention & control*
  • Humans
  • Informed Consent
  • Pandemics / prevention & control*
  • Patient Safety
  • Pneumonia, Viral / prevention & control*
  • United States
  • United States Food and Drug Administration
  • Viral Vaccines / adverse effects
  • Viral Vaccines / standards*

Substances

  • COVID-19 Vaccines
  • Viral Vaccines